KLK13

gene product
KLK-L4
Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. This gene is one of the fifteen kallikrein subfamily members located in a cluster on chromosome 19. Expression of this gene is regulated by steroid hormones and may be useful as a marker for breast cancer. [provided by RefSeq, Jan 2017]
More gene data

Featured antibodies

Antibodies

 

Filters

Application

Antibodypedia Validation Initiative

Validation method

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

Antibody

  or   Clear
Enhanced validation
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Validated within AVI
Eligible for validation within AVI
277 antibodies from 28 providers.

Antibody properties

General

Applications

or Cancel
Antibody
Novus Biologicals
31 antibodies
R&D Systems
3 antibodies
GeneTex
4 antibodies
OriGene
5 antibodies
NovoPro Bioscience Inc.
6 antibodies
antibodies-online
78 antibodies
Atlas Antibodies
1 antibody
Invitrogen Antibodies
8 antibodies
LifeSpan BioSciences, Inc.
58 antibodies
Acris Antibodies GmbH
5 antibodies
Biorbyt
11 antibodies
Abbkine Scientific Co.Ltd.
1 antibody
MyBioSource
6 antibodies
Abnova Corporation
3 antibodies
Aviva Systems Biology
2 antibodies
RabMAbs
1 antibody
Creative Biolabs
11 antibodies
St John's Laboratory
2 antibodies
Boster Biological Technology
1 antibody
RayBiotech, Inc.
1 antibody
United States Biological
15 antibodies
GenWay
2 antibodies
ProSci
2 antibodies
Sigma-Aldrich
2 antibodies
EMD Millipore
1 antibody
Leading Biology
1 antibody
Abgent
1 antibody